Congenital hyperinsulinemia with grade 4 intraventricular hemorrhage: a case report with a 2-year follow-up

Jahanara Begum-Hasan1

  • 1Department of Pediatrics, Carilion Clinic Children's Hospital, and Virginia Tech Carilion School of Medicine, Roanoke, Virginia.

Insights

Severe hypoglycemia in a late preterm infant led to massive intraventricular hemorrhage. Prompt diagnosis and management of neonatal hypoglycemia are crucial to prevent severe neurological complications.

Area of Science:

  • Neonatal Medicine
  • Pediatric Neurology
  • Endocrinology

Background:

  • Congenital hyperinsulinemia is a rare cause of persistent neonatal hypoglycemia.
  • Intraventricular hemorrhage (IVH) is a serious complication in preterm infants, but its association with hypoglycemia is infrequently reported.

Observation:

  • A late preterm infant presented with severe hypoglycemia unresponsive to high glucose infusion rates.
  • Cranial computed tomography revealed extensive intraventricular hemorrhage with intraparenchymal extension on day 2 of life.
  • The infant was diagnosed with congenital hyperinsulinemia and treated with diazoxide, achieving normoglycemia.

Findings:

  • The extensive intraventricular hemorrhage was considered secondary to prolonged, severe hypoglycemia.
  • The infant developed global developmental delay at 26 months of age.

Implications:

  • This case underscores the critical need for early recognition and management of neonatal hypoglycemia.
  • Prompt intervention can mitigate the risk of severe neurological sequelae, such as developmental delay, associated with prolonged hypoglycemia.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...